The Effect of Heparan Sulfate Application on Bone Formation during Distraction Osteogenesis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Gdalevitch, Marie ^a   Kasaai, Bahar ^a   Alam, Norine ^a   Dohin, Bruno ^b   Lauzier, Dominique ^a   Hamdy, Reggie C ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b UNIVERSITÉ JEAN MONNET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HEPARAN SULFATE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE TISSUE; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; FORCE; HEALING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; POSTOPERATIVE INFECTION; PROTEIN EXPRESSION; RADIOLOGY; RIGIDITY; SCORING SYSTEM; SIGNAL TRANSDUCTION; WILD TYPE; WOUND DEHISCENCE; X RAY ANALYSIS;

ANIMALS; BIOMECHANICS; BONE MORPHOGENETIC PROTEINS; DOWN-REGULATION; HEPARITIN SULFATE; MALE; MICE; MICE, INBRED C57BL; OSTEOGENESIS; OSTEOGENESIS, DISTRACTION; POSTOPERATIVE COMPLICATIONS; SIGNAL TRANSDUCTION; TIBIA; X-RAY MICROTOMOGRAPHY;

EID: 84874089822     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056790     Document Type: Article

References (52)

1. Ilizarov G, (1990) Clinical application of the tension-stress effect for limb lengthening. Clinical Orthopaedics & Related Research 250: 8-26.
2. Sailhan F, (2011) Bone lengthening (distraction osteogenesis): a literature review. Osteoporos Int 22: 2011-2015.
3. Hu J, Li J, Wang D, Buckley M, Agarwal S, (2002) Differences in mandibular distraction osteogenesis after corticotomy and osteotomy. Int J Oral Maxillofac Surg 31: 185-189.
4. Hu J, Qi M, Zou S, Li J, Luo E, (2007) Callus formation enhanced by BMP-7 ex vivo gene therapy during distraction osteogenesis in rats. J Orthop Res 25: 241-251.
5. Isefuku S, Joyner CJ, Simpson AH, (2000) A murine model of distraction osteogenesis. Bone 27: 661-665.
6. Krawczyk A, Kuropka P, Kuryszko J, Wall A, Dragan S, et al. (2007) Experimental studies on the effect of osteotomy technique on the bone regeneration in distraction osteogenesis. Bone 40: 781-791.
7. Devescovi V, Leonardi E, Ciapetti G, Cenni E, (2008) Growth factors in bone repair. Chir Organi Mov 92: 161-168.
8. Haque T, Amako M, Nakada S, Lauzier D, Hamdy RC, (2007) An immunohistochemical analysis of the temporal and spatial expression of growth factors FGF 1, 2 and 18, IGF 1 and 2, and TGFbeta1 during distraction osteogenesis. Histol Histopathol 22: 119-128.
9. Chen G, Deng C, Li YP, (2012) TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8: 272-288.
10. Rengachary S, (2002) Bone morphogenetic proteins: basic concepts. Neurosurgical Focus 13: 1-6.
11. Tsuji K, Bandyopadhyay A, Harfe B, Cox K, Kakar S, et al. (2006) BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38: 1424-1429.
12. Haque T, Hamade F, Alam N, Kotsiopriftis M, Lauzier D, et al. (2008) Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis. Bone 42: 1144-1153.
13. Haque T, Mandu-Hrit M, Rauch F, Lauzier D, Tabrizian M, et al. (2006) Immunohistochemical localization of bone morphogenetic protein-signaling Smads during long-bone distraction osteogenesis. J Histochem Cytochem 54: 407-415.
14. Mandu-Hrit M, Haque T, Lauzier D, Kotsiopriftis M, Rauch F, et al. (2006) Early injection of OP-1 during distraction osteogenesis accelerates new bone formation in rabbits. Growth Factors 24: 172-183.
15. Hamdy R, Amako M, Beckman L, Kawaguchi M, Rauch F, et al. (2003) Effects of osteogenic protein-1 on distraction osteogenesis in rabbits. Bone 33: 248-255.
16. Giannoudis P, Kanakaris N, Einhorn T, (2007) Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence. Osteoporos Int 18: 1565-1581.
17. Groeneveld E, Burger E, (2000) Bone morphogenetic proteins in human bone regeneration. European Journal of Endocrinology 142: 9.
18. Harwood P, Giannoudis P, (2005) Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. eds 4: 75-89.
19. Okamoto M, Murai J, Yoshikawa H, Tsumaki N, (2006) Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 21: 1022-1033.
20. Jiao X, Billings P, O'Connell M, Kaplan F, Shore E, et al. (2007) Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. Journal of Biological Chemistry 282: 1080.
21. Chen D, Zhao M, Mundy GR, (2004) Bone Morphogenetic Proteins. Growth Factors 22: 233-241.
22. Coombe D, Kett W, (2005) Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cellular and Molecular Life Sciences (CMLS) 62: 410-424.
23. Kjellen L, Lindahl U, (1991) Proteoglycans: structures and interactions. Annual review of biochemistry 60: 443-475.
24. Khan S, Nelson M, Pan C, Gaffney P, Gupta P, (2008) Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity. American Journal of Physiology- Cell Physiology 294: C1387.
25. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, et al. (2003) Sulfated Polysaccharides Enhance the Biological Activities of Bone Morphogenetic Proteins*. Journal of Biological Chemistry 278: 43229-43235.
26. Irie A, Habuchi H, Kimata K, Sanai Y, (2003) Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochemical and Biophysical Research Communications 308: 858-865.
27. Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, et al. (2008) Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. Journal of Cellular Physiology 216.
28. Ohkawara B, Iemura S, ten Dijke P, Ueno N, (2002) Action range of BMP is defined by its N-terminal basic amino acid core. Current Biology 12: 205-209.
29. Paine-Saunders S, Viviano B, Economides A, Saunders S, (2002) Heparan sulfate proteoglycans retain Noggin at the cell surface a potential mechanism for shaping bone morphogenetic protein gradients. Journal of Biological Chemistry 277: 2089-2096.
30. Fisher M, Li Y, Seghatoleslami M, Dealy C, Kosher R, (2006) Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biology 25: 27-39.
31. Jackson R, McDonald M, Nurcombe V, Little D, Cool S, (2006) The use of heparan sulfate to augment fracture repair in a rat fracture model. Journal of Orthopaedic Research 24.
32. Woodruff MA, Rath SN, Susanto E, Haupt LM, Hutmacher DW, et al. (2007) Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial model. J Mol Histol 38: 425-433.
33. Rider Christopher C, Mulloy B, (2010) Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochemical Journal 429: 1-12.
34. Esko J, Lindahl U, (2001) Molecular diversity of heparan sulfate. Am Soc Clin Investig pp. 169-173.
35. Gallagher J, (2001) Heparan sulfate: growth control with a restricted sequence menu. Am Soc Clin Investig pp. 357-361.
36. Eckert R, Ragg H, (2003) Zinc ions promote the interaction between heparin and heparin cofactor II. FEBS letters 541: 121-125.
37. Ricard-Blum S, Feraud O, Lortat-Jacob H, Rencurosi A, Fukai N, et al. (2004) Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations. Journal of Biological Chemistry 279: 2927-2936.
38. Olwin B, (1992) Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. Journal of Cell Biology 118: 631-639.
39. Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz D, (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
40. Hamdy RC, Silvestri A, Rivard CH, Ehrlich M, (1997) [Histologic evaluation of bone regeneration in cases of limb lengthening by Ilizarov's technique. An experimental study in the dog]. Ann Chir 51: 875-883.
41. Troulis M, C C, MJ ON, LB K, (2003) Ultrasound: assessment of the distraction osteogenesis wound in patients undergoing mandibular lengthening. J Oral Maxillofac Surg 61: 1144-1149.
42. Haidar ZS, Tabrizian M, Hamdy RC, (2010) A hybrid rhOP-1 delivery system enhances new bone regeneration and consolidation in a rabbit model of distraction osteogenesis. Growth Factors 28: 44-55.
43. Tavakoli K, Yu Y, Shahidi S, Bonar F, Walsh WR, et al. (1999) Expression of growth factors in the mandibular distraction zone: a sheep study. Br J Plast Surg 52: 434-439.
44. Yeung HY, Lee SK, Fung KP, Leung KS, (2001) Expression of basic fibroblast growth factor during distraction osteogenesis. Clin Orthop Relat Res pp. 219-229.
45. Kasaai B, Moffatt P, Al-Salmi L, Lauzier D, Lessard L, et al. (2012) Spatial and temporal localization of WNT signaling proteins in a mouse model of distraction osteogenesis. J Histochem Cytochem 60: 219-228.
46. Alam N, St-Arnaud R, Lauzier D, Rosen V, Hamdy RC, (2009) Are endogenous BMPs necessary for bone healing during distraction osteogenesis? Clin Orthop Relat Res 467: 3190-3198.
47. Colburn NT, Zaal KJ, Wang F, Tuan RS, (2009) A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum 60: 1694-1703.
48. Yeung H, Lee S, Fung K, Leung K, (2001) Expression of basic fibroblast growth factor during distraction osteogenesis. Clin Orthop Relat Res 385: 219-229.
49. Jasuja R, Allen BL, Pappano WN, Rapraeger AC, Greenspan DS, (2004) Cell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordin. J Biol Chem 279: 51289-51297.
50. Economides A, Stahl N, Harland R, (2000) Modified noggin polypeptide and compositions. Google Patents.
51. Schlessinger J, Lax I, Lemmon M, (1995) Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83: 357.
52. Borza D, Morgan W, (1998) Histidine-Proline-rich Glycoprotein as a Plasma pH Sensor Modulation of its Interaction With Glycosaminoglycans by pH and Metals. Journal of Biological Chemistry 273: 5493-5499.